First report of ISKpn26 element mediating mgrB gene disruption in the ST1 colistin- and carbapenem-resistant Klebsiella pneumoniae cluster isolated from a patient with chest infection

Xiaosi Li,Siquan Shen,Yan Feng,Heping Shen,Fupin Hu,Xiaoyan Wu
DOI: https://doi.org/10.1128/spectrum.00952-24
IF: 3.7
2024-09-25
Microbiology Spectrum
Abstract:Colistin is used as a last-line therapy against carbapenem-resistant Klebsiella pneumoniae (CRKP). However, colistin resistance in Klebsiella pneumoniae is increasingly reported worldwide. ... Of note, this chapter gives an update on colistin resistance in sequence type 1 Klebsiella pneumoniae, by focusing on the mgrB disrupted by ISKpn26 element.
microbiology
What problem does this paper attempt to address?